![](https://www.alpha-mos.com/sites/default/files/styles/image_background/public/alphamos/articles/images/photo-medical02_1.jpg?itok=dW16HL8U)
Report on BOYDSense in "le Magazine de la santé"
France 5 presents the diabetes monitoring device from BOYDSense
16/06/2023
![](https://www.alpha-mos.com/sites/default/files/styles/image_une/public/alphamos/articles/images/2023-06-16-magazine-sante2.png?itok=eWR7-QfD)
In France, more than 3.9 million persons suffer from diabetes.
BOYDSense, the Alpha MOS subsidiary dedicated to medical applications, works on a pain-free device to monitor glucose levels with exhaled breath.
Along with Toulouse CHU, a clinical study has been conducted on 130 patients with Type-2 that measured their glucose level by blood analysis and breath analysis.
Dr. Pierre Gourdy, who is the investigator of the study comments: “More than 98% of the values showed high correlation between blood testing and breath measurement. The results are very promising.”
See the report in the Magazine de la santé on France 5 - June 16, 2023 (10:34)